Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers.

about

Clinical Application of Detecting 21-Gene Recurrence Score in Predicating Prognosis and Therapy Response of Patients with Breast Cancer from Two Medical Centers.

Item

http://www.wikidata.org/entity/Q48110842

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinical Application of Detect ...... ncer from Two Medical Centers.

@en

Clinical Application of Detect ...... ncer from Two Medical Centers.

@nl

type

Item

label

Clinical Application of Detect ...... ncer from Two Medical Centers.

@en

Clinical Application of Detect ...... ncer from Two Medical Centers.

@nl

prefLabel

Clinical Application of Detect ...... ncer from Two Medical Centers.

@en

Clinical Application of Detect ...... ncer from Two Medical Centers.

@nl

P1476

Clinical Application of Detect ...... ancer from Two Medical Centers

@en

P2093

Chongwen Xu

http://www.w3.org/2001/XMLSchema#string

Gang Li

http://www.w3.org/2001/XMLSchema#string

Hong Ren

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Jinying Meng

http://www.w3.org/2001/XMLSchema#string

Ning Du

http://www.w3.org/2001/XMLSchema#string

Shou-Ching Tang

http://www.w3.org/2001/XMLSchema#string

Sida Qin

http://www.w3.org/2001/XMLSchema#string

Xin Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients

Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.

Cancer specific mortality in insulin-treated type 2 diabetes patients.

The effect of Oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists.

Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer.

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.

The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

P304

639-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07357907.2017.1405015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jichang Wang

Guodong Xiao

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29243989

http://www.w3.org/2001/XMLSchema#string